Cargando…
Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
BACKGROUND: Functional iron deficiency (FID) may cause erythropoietin resistance in patients under hemodialysis (HD). Since the role of chronic inflammation or oxidative stress in its pathogenesis is unclear, controversy remains to whether intravenous iron or intravenous ascorbic acid (an antioxidan...
Autores principales: | Sedighi, Omid, Makhlough, Atieh, Janbabai, Ghasem, Neemi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842563/ https://www.ncbi.nlm.nih.gov/pubmed/24350091 http://dx.doi.org/10.5812/numonthly.12038 |
Ejemplares similares
-
Comparing the Levels of Trace Elements in Patients With Diabetic Nephropathy and Healthy Individuals
por: Makhlough, Atieh, et al.
Publicado: (2015) -
Options for intravenous iron supplementation in hemodialysis patients
por: Kong, Ji Yoon, et al.
Publicado: (2020) -
Oral versus intravenous iron therapy in iron deficiency anemia: An observational study
por: Das, Samarendra N., et al.
Publicado: (2020) -
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020) -
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)